abstract |
The invention concerns 9-substituted bicylo[3.3.0]octane derivaties of formula (I) and their physiologically acceptable bases, and also the $g(a)-, $g(b)- or $g(g)-cyclodextrin clathrates, and the compounds of formula (I) encapsulated in liposomes. The invention also concerns methods of preparing such compounds and their use in pharmaceuticals. |